Finance

Lists
Why is 524669 up 2,30%?
Dive Deeper
524669:BOM
Hester Biosciences Ltd
2 240,00 ₹
+2,30%
(+50,40) 1D
16 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524669...
Open
2 206,70 ₹
High
2 240,00 ₹
Low
2 206,70 ₹
Mkt. cap
19,03 մլրդ
Avg. vol.
373,00
Volume
69,00
Dividend
0,49%
Quarterly dividend
2,75 ₹
Ex-dividend date
14 հլս, 2026 թ.
P/E ratio
14,12
52-wk high
2 669,00 ₹
52-wk low
1 250,95 ₹
EPS
158,68 ₹
Shares outstanding
8,51 մլն
No. of employees
483
Open
2 206,70 ₹
High
2 240,00 ₹
Low
2 206,70 ₹
Mkt. cap
19,03 մլրդ
Avg. vol.
373,00
Volume
69,00
Dividend
0,49%
Quarterly dividend
2,75 ₹
Ex-dividend date
14 հլս, 2026 թ.
P/E ratio
14,12
52-wk high
2 669,00 ₹
52-wk low
1 250,95 ₹
EPS
158,68 ₹
Shares outstanding
8,51 մլն
No. of employees
483
News stories
From web sources and news partners
Profile
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
About Hester Biosciences Ltd
CEO-
Employees483
Founded1983
Headquarters-
Sector-
Websitehester.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
709,69 մլն
774,15 մլն
1,02 մլրդ
772,44 մլն
Cost of goods sold
193,19 մլն
207,28 մլն
251,52 մլն
170,79 մլն
Cost of revenue
193,19 մլն
207,28 մլն
251,52 մլն
170,79 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155,01 մլն
155,18 մլն
264,13 մլն
148,84 մլն
Operating expense
442,86 մլն
433,25 մլն
465,39 մլն
444,32 մլն
Total operating expenses
636,05 մլն
640,53 մլն
716,91 մլն
615,11 մլն
Operating income
73,64 մլն
133,62 մլն
299,41 մլն
157,33 մլն
Other non operating income
97,27 մլն
6,69 մլն
-133,21 մլն
16,43 մլն
EBT including unusual items
170,36 մլն
135,24 մլն
250,89 մլն
1,02 մլրդ
EBT excluding unusual items
170,36 մլն
135,24 մլն
203,96 մլն
163,33 մլն
Income tax expense
27,05 մլն
42,14 մլն
85,42 մլն
49,50 մլն
Effective tax rate
15,88%
31,16%
34,05%
4,87%
Other operating expenses
244,31 մլն
233,76 մլն
58,89 մլն
225,04 մլն
Net income
144,49 մլն
87,65 մլն
159,83 մլն
969,81 մլն
Net profit margin
20,36%
11,32%
15,73%
125,55%
Earnings per share
-
-
-
-
Interest and investment income
-
-
15,79 մլն
-
Interest expense
-22,07 մլն
-18,22 մլն
-15,77 մլն
-30,80 մլն
Net interest expenses
-22,07 մլն
-18,22 մլն
20,00 հզր
-30,80 մլն
Depreciation and amortization charges
43,54 մլն
44,31 մլն
59,14 մլն
70,44 մլն
EBITDA
116,32 մլն
174,66 մլն
330,34 մլն
188,26 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps